Table 3 Factors associated with PSAGN at Ayder comprehensive specialized Hospital and Mekelle Hospital Mekelle. 2013–2015 (n = 334)
Variables | Outcome | COR 95% CI | AOR 95% CI | |
|---|---|---|---|---|
Positive | Negative | |||
Age (years) | ||||
< 5 | 39 (79.6%) | 10 (20.4%) | 3.900 (1.034–14.714) | 4.593 (1.013–20.811)** |
5–9 | 114 (79.2%) | 30 (20.8%) | 3.800 (1.143–12.628) | 2.865 (0.735–11.178) |
10–14 | 85 (67.9%) | 44 (34.1) | 1.932 (0.588–6.342) | 1.510 (0.399–5.714) |
15–18 | 6 (50%) | 6 (50%) | 1.00 | 1.00 |
Residential area | ||||
Urban | 63 (82.9%) | 13 (17.1%) | 1.00 | 1.00 |
Rural | 181 (70.2%) | 77 (29.8%) | 0.485 (0.252–0.933) | 0.580 (0.277–1.214) |
Clinical | ||||
General body swelling | 191 (69.7%) | 83 (30.3%) | 0.304 (0.133–0.696) | 0.480 (0.190–1.211) |
Facial swelling | 53 (88.3%) | 7 (11.7%) | 1.00 | 1.00 |
Nutritional status | ||||
Well nutrition | 31 (59.6%) | 21 (40.4%) | 1.00 | 1.00 |
Under nutrition | 213 (75.5%) | 69 (24.5%) | 2.091 (1.128–3.875) | 0.451 (0.116–1.750) |
Duration of infection | ||||
Less than 2 weeks | 33 (56.9%) | 25 (43.1%) | 1.00 | 1.00 |
Greater than 2 weeks | 211 (76.4%) | 65 (23.6%) | 2.459 (1.364–4.434) | 4.314 (1.201–15.491)** |
Source of infection | ||||
Yes | 226 (77.7%) | 65 (22.3%) | 4.829 (2.482–9.397) | 3.909 (1.747–8.746)** |
No | 18 (41.9%) | 25 (58.1%) | 1.00 | 1.00 |
Length of stay in hospital (weeks) | ||||
< 2 | 33 (43.4%) | 43 (56.6%) | 1.00 | 1.00 |
> 2 | 211 (81.8%) | 47 (18.2%) | 5.850 (3.365–10.168) | 4.456 (2.426–8.184)** |